Tag Archives: KetamineDerived

FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression

More than 16 million Americans experience depression and an estimated 30 to 40% are not helped by first-line treatments including antidepressants and psychotherapy. Getty The U.S. Food & Drug Administration Tuesday approved Johnson & Johnson’s ketamine-derived nasal spray Spravato for treatment-resistant depression. The green light means ketamine—an anesthetic abused as a party drug but promoted… Read More »